CASP1 and diabetic kidney disease: A study of traditional Chinese medicine for the treatment of diabetic nephropathy revealed that ginsenoside Rh2 could ultimately alleviate diabetic nephropathy by inhibiting LMP, reducing the expression of CTSB and cathepsin L, and inhibiting caspase-1-mediated pyroptosis (83, 84).